Department of Anaesthesia, Lausanne University Hospital, Lausanne, Switzerland.
Department of Anaesthesia, Toronto Western Hospital, University of Toronto, Toronto, Canada.
Anaesthesia. 2019 May;74(5):651-662. doi: 10.1111/anae.14582. Epub 2019 Feb 25.
Opioids are administered peri-operatively for postoperative analgesia, and intra-operatively to control the sympathetic response to surgical stimuli, frequently as a surrogate for presumed pain. However, opioid use during surgery is a matter of dispute in contemporary practice and carries the risk of side-effects such as postoperative nausea and vomiting. This meta-analysis investigated whether opioid-inclusive, compared with opioid-free anaesthesia, would reduce postoperative pain, without increasing the rate of postoperative nausea and vomiting. The electronic databases Medline and PubMed were searched until June 2018. We included trials investigating pain outcomes and comparing any type of intra-operative opioid administration with placebo injection or no intra-operative opioid. Most meta-analyses were performed using a random effects model. We rated the quality of evidence for each outcome. The primary outcome was pain score at rest (analogue scale, 0-10) at two postoperative hours. Our secondary outcomes included the rate of postoperative nausea and vomiting within the first 24 postoperative hours and length of stay in the recovery area. Twenty-three randomised controlled trials, including 1304 patients, were identified. Pain scores at rest at two postoperative hours were equivalent in the opioid-inclusive and opioid-free groups with a mean difference (95%CI) of 0.2 (-0.2 to 0.5), I = 83%, p = 0.38 and a high quality of evidence. Similarly, there was high-quality evidence that the rate of postoperative nausea and vomiting was reduced in the opioid-free group, with a risk ratio (95%CI) of 0.77 (0.61-0.97), I = 16%, p = 0.03 and high-quality evidence for a similar length of stay in the recovery area, the mean difference (95%CI) being 0.6 (-8.2 to 9.3), min, I = 60%, p = 0.90. As there is strong evidence that opioid-inclusive anaesthesia does not reduce postoperative pain, but is associated with more postoperative nausea and vomiting, when compared with opioid-free anaesthesia, we suggest that anaesthetists should reconsider their intra-operative opioid choices on a case-by-case basis.
阿片类药物在围手术期用于术后镇痛,并在手术期间用于控制手术刺激引起的交感反应,通常作为假定疼痛的替代物。然而,手术期间使用阿片类药物在当代实践中存在争议,并存在术后恶心和呕吐等副作用的风险。这项荟萃分析研究了与无阿片类药物麻醉相比,包含阿片类药物的麻醉是否会减轻术后疼痛,而不会增加术后恶心和呕吐的发生率。电子数据库 Medline 和 PubMed 检索至 2018 年 6 月。我们纳入了研究疼痛结局并比较任何类型的术中阿片类药物给药与安慰剂注射或无术中阿片类药物的试验。大多数荟萃分析使用随机效应模型进行。我们为每个结局评定证据质量。主要结局是术后 2 小时静息时的疼痛评分(模拟量表,0-10)。我们的次要结局包括术后 24 小时内恶心和呕吐的发生率以及恢复区的住院时间。确定了 23 项随机对照试验,包括 1304 名患者。术后 2 小时静息时的疼痛评分在包含阿片类药物和无阿片类药物组之间相当,平均差异(95%CI)为 0.2(-0.2 至 0.5),I = 83%,p = 0.38,证据质量高。同样,高质量证据表明,无阿片类药物组的术后恶心和呕吐发生率降低,风险比(95%CI)为 0.77(0.61-0.97),I = 16%,p = 0.03,且恢复区的住院时间相似,平均差异(95%CI)为 0.6(-8.2 至 9.3),min,I = 60%,p = 0.90。由于有强有力的证据表明,与无阿片类药物麻醉相比,包含阿片类药物的麻醉并不能减轻术后疼痛,但会增加术后恶心和呕吐的发生,因此我们建议麻醉师应根据具体情况重新考虑其术中阿片类药物的选择。